A new link between heart failure and diabetes emerges
Recent research investigates the complex relationship between heart failure events and the onset of new diabetes in patients with heart failure and mildly reduced or preserved ejection fraction. The study examines the role of the medication finerenone in this interplay, analyzing whether treatment can influence the risk of developing diabetes following a heart failure hospitalization or episode. This work highlights a critical bidirectional connection between two major chronic conditions, suggesting that cardiovascular events may be a potent trigger for metabolic dysfunction.
Why it might matter to you: For emergency physicians managing acute chest pain, respiratory failure, or decompensated heart failure, this research underscores a key long-term risk for discharged patients. Recognizing heart failure hospitalization as a potential trigger for new-onset diabetes can inform more vigilant follow-up and screening protocols in the emergency department discharge process. This connection adds a crucial metabolic dimension to post-acute care planning for cardiac patients.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
